Noridian implements temporary ICD-10 code fix for mammography and breast biopsy policies

February 07, 2018
Area(s) of Interest: Commercial Payors Payor Issues and Reimbursement Women's Health 

California’s Medicare contractor, Noridian, recently implemented a temporary correction to the National Coverage Determination policies for mammograms (NCD 220.4) and percutaneous image-guided breast biopsies (NCD 220.13), allowing for the acceptance of new 2018 ICD-10 diagnosis codes. 

For both NCD 220.4 and NCD 220.13, the new ICD-10 diagnoses codes of N63.11-N63.14, N63.21-N63.24, N63.31, N63.32, N63.41 and N63.42 were not being accepted from October 1, 2017, to January 2, 2018. These new ICD-10 diagnosis codes replaced the former diagnosis, N63, which was an unspecified code and end-dated on September 30, 2017.

The temporary correction to accept the new ICD-10 codes for these two policies became effective January 2, 2018; a permanent correction will be implemented April 2, 2018. For claims that processed incorrectly from October 1, 2017, to January 2, 2018, a mass adjustment will be completed by Noridian after the permanent implementation on April 2, 2018. No provider action is required.

For additional details, click here.


Was this article helpful?    
Download the New CMADocs app!

Download the new CMADocs app!

CMA's new mobile app lets you connect with your colleagues and engage with CMA content!  Download the "CMADocs" app today from the Apple or Google Play app stores for daily news updates, events calendar, resource library and more.

Latest News

Load More